Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Magento Expands Its Cloud-Based Commerce Ecosystem with Microsoft and Joyent

Business Wire January 12, 2015

First Companies Move into FutuRx Biotech Incubator in Israel

PR Newswire January 12, 2015

Novocure Announces the Completion of Enrollment of its PANOVA Trial of Tumor Treating Fields Plus Gemcitabine for Treatment of Pancreatic Cancer

Business Wire January 12, 2015

FDA Approves Antria Phase 2 Stem Cell Clinical Trials

Business Wire January 12, 2015

Helomics Supports the Work of the UK's Personalised Healthcare Alliance

Business Wire January 12, 2015

Kane Biotech Announces Grant of Options

Marketwired January 12, 2015

Georgia Bio Community Awards Honor Academic, Service, Association Leaders

Business Wire January 12, 2015

Rocky Mountain Cancer Centers Enhances Services in South Denver, Adding Two New Medical Oncologists and Greenwood Village Treatment Center

Business Wire January 12, 2015

Amorfix announces strategic plan to centralize operations in South San Francisco and focus on neurodegenerative disease

Canada NewsWire January 12, 2015

Dako, an Agilent Technologies Company, and Cell Signaling Technology announce partnership within companion diagnostics

GlobeNewswire January 12, 2015

Ultragenyx Announces Intent to File for Conditional Approval in Europe for Sialic Acid Extended-Release Tablets in Hereditary Inclusion Body Myopathy

GlobeNewswire January 12, 2015

GeoVax Provides Progress Report on Its Ebola Vaccine Program

Marketwired January 12, 2015

Asuragen to Join Leading UK Cancer Research Consortium to Develop miRNA Based Sequencing Tests for Early Detection and Screening of Cancer

Business Wire January 12, 2015

JDRF to Honor Scientists for Their Outstanding Work in Advancing Type 1 Diabetes Research

PR Newswire January 12, 2015

World-premiere: All-new 2015 Alfa Romeo 4C Spider Delivers Race-inspired Performance, Advanced Technologies, Seductive Italian Style, and now an Even More Exhilarating Driving Experience With Open-air Freedom

PR Newswire January 12, 2015

Sorrento Provides Status Update on the Cynviloq(TM) Registrational TRIBECA(TM) Study

PR Newswire January 12, 2015

23andMe Announces Collaboration with Pfizer Inc. to Conduct Genetic Research Through 23andMe's Research Platform

PR Newswire January 12, 2015

Amarantus Announces Acquisition of Specialized Neuro-Diagnostics Company, DioGenix

GlobeNewswire January 12, 2015

22nd Century Group Establishes Trade Partners Program to Promote the Sale of RED SUN Cigarettes

Business Wire January 12, 2015

Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors

PR Newswire January 12, 2015